Extracellular Nucleic Acids in the Diagnosis and Progression of Colorectal Cancer
- PMID: 35954375
- PMCID: PMC9367600
- DOI: 10.3390/cancers14153712
Extracellular Nucleic Acids in the Diagnosis and Progression of Colorectal Cancer
Abstract
Colorectal cancer (CRC) is the 3rd most common malignant neoplasm worldwide, with more than two million new cases diagnosed yearly. Despite increasing efforts in screening, many cases are still diagnosed at a late stage, when mortality is high. This paper briefly reviews known genetic causes of CRC (distinguishing between sporadic and familial forms) and discusses potential and confirmed nucleic acid biomarkers obtainable from liquid biopsies, classified by their molecular features, focusing on clinical relevance. We comment on advantageous aspects such as better patient compliance due to blood sampling being minimally invasive, the possibility to monitor mutation characteristics of sporadic and hereditary CRC in a disease showing genetic heterogeneity, and using up- or down-regulated circulating RNA markers to reveal metastasis or disease recurrence. Current difficulties and thoughts on some possible future directions are also discussed. We explore current evidence in the field pointing towards the introduction of personalized CRC management.
Keywords: biomarkers; cell-free nucleic acids; colorectal cancer; liquid biopsy; non-invasive diagnosis.
Conflict of interest statement
J.S., O.P. and T.S. are employees of Geneton Ltd., participating in a research and development activity that does not conflict with the manuscript’s content. V.R. is an employee of Medirex Group Academy n.p.o., and participated in a research and project activity with no potential conflict of interest to the proposed manuscript. All remaining authors declare no conflict of interest.
Figures

Similar articles
-
Circulating Tumor Cells and Cell-free Nucleic Acids as Biomarkers in Colorectal Cancer.Curr Pharm Des. 2023;29(10):748-765. doi: 10.2174/1381612829666230308102611. Curr Pharm Des. 2023. PMID: 36892023 Review.
-
Liquid Biopsy and Artificial Intelligence as Tools to Detect Signatures of Colorectal Malignancies: A Modern Approach in Patient's Stratification.Front Oncol. 2022 Mar 8;12:856575. doi: 10.3389/fonc.2022.856575. eCollection 2022. Front Oncol. 2022. PMID: 35356214 Free PMC article. Review.
-
Clinical Applications of Liquid Biopsy in Colorectal Cancer Screening: Current Challenges and Future Perspectives.Cells. 2022 Nov 4;11(21):3493. doi: 10.3390/cells11213493. Cells. 2022. PMID: 36359889 Free PMC article. Review.
-
Epigenetic Landscape of Liquid Biopsy in Colorectal Cancer.Front Cell Dev Biol. 2021 Feb 5;9:622459. doi: 10.3389/fcell.2021.622459. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 33614651 Free PMC article. Review.
-
Liquid Biopsy as a Source of Nucleic Acid Biomarkers in the Diagnosis and Management of Lynch Syndrome.Int J Mol Sci. 2022 Apr 13;23(8):4284. doi: 10.3390/ijms23084284. Int J Mol Sci. 2022. PMID: 35457101 Free PMC article. Review.
Cited by
-
Increased amounts of cell-free DNA released from a culture with a high content of cancer stem cells.Front Cell Dev Biol. 2025 Mar 28;13:1499936. doi: 10.3389/fcell.2025.1499936. eCollection 2025. Front Cell Dev Biol. 2025. PMID: 40226589 Free PMC article.
-
Telomere Length Changes in Cancer: Insights on Carcinogenesis and Potential for Non-Invasive Diagnostic Strategies.Genes (Basel). 2023 Mar 14;14(3):715. doi: 10.3390/genes14030715. Genes (Basel). 2023. PMID: 36980987 Free PMC article. Review.
-
Identification of potential key genes for colorectal cancer based on bioinformatics analysis.Medicine (Baltimore). 2023 Dec 22;102(51):e36615. doi: 10.1097/MD.0000000000036615. Medicine (Baltimore). 2023. PMID: 38134110 Free PMC article.
-
Cell-Free DNA: Unveiling the Future of Cancer Diagnostics and Monitoring.Cancers (Basel). 2024 Feb 4;16(3):662. doi: 10.3390/cancers16030662. Cancers (Basel). 2024. PMID: 38339412 Free PMC article.
-
Emerging Role of Tumor-Educated Platelets as a New Liquid Biopsy Tool for Colorectal Cancer.Arch Iran Med. 2023 Aug 1;26(8):447-454. doi: 10.34172/aim.2023.68. Arch Iran Med. 2023. PMID: 38301107 Free PMC article. Review.
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources